Rexam Industries Corp. v. Eastman Kodak Company and Avery Dennison Corporation

182 F.3d 1366, 51 U.S.P.Q. 2d (BNA) 1457, 1999 U.S. App. LEXIS 16013, 1999 WL 499491
CourtCourt of Appeals for the Federal Circuit
DecidedJuly 16, 1999
Docket98-1279
StatusPublished
Cited by10 cases

This text of 182 F.3d 1366 (Rexam Industries Corp. v. Eastman Kodak Company and Avery Dennison Corporation) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Rexam Industries Corp. v. Eastman Kodak Company and Avery Dennison Corporation, 182 F.3d 1366, 51 U.S.P.Q. 2d (BNA) 1457, 1999 U.S. App. LEXIS 16013, 1999 WL 499491 (Fed. Cir. 1999).

Opinion

LOURIE, Circuit Judge.

This case comes to us on certification of two questions by the United States District Court for the Western District of North Carolina, Civil Action No. 95-CV-62, in an interference case. The district court certified the following questions for appeal:

1. Can a patent applicant that prevails in an interference before the Board of Patent Appeals and Interferences based only on the constructive reduction to practice represented by its patent application, continue to contest priority in a succeeding civil action under 35 U.S.C. § 146, notwithstanding the patent applicant’s acquiescence, during pendency of that Section 146 action, in entry of final judgment against it on priority grounds in another interference involving the same inventions but a different adversary?
2. If the answer to the above question is in the negative, must the Board’s decision awarding priority to the patent applicant and against a patentee be reversed, with judgment entered in favor of the patentee regarding priority?

We answer the first certified question in the affirmative for the reasons given here-inbelow. Consequently, we do not reach the second certified question.

BACKGROUND

Two interference proceedings, both involving an identical interference count, are relevant to this appeal. 1 The first is Interference No. 102,667 (the ’667 interference), declared by the U.S. Patent and Trademark Office (PTO) Board of Patent Appeals and Interferences in 1991 between the claims of a U.S. patent assigned to Rexam Industries Corp. and certain claims of a U.S. patent application assigned to Eastman Kodak Co. The second is Interference No. 103,738 (the ’738 interference), declared by the Board in 1996 between the same claims of Kodak’s application and certain claims of an application assigned to Avery Dennison Corp. These interferences, and the challenge to the ’667 interference brought by Rexam following the Board’s final judgment in that case, are discussed below.

The ’667 Interference

The ’667 interference count involved all of the claims of Rexam’s U.S. Patent 4,931,324 (the ’324 patent) and claims 66-76 of Kodak’s U.S. Patent Application 07/609,050 (the ’050 application). Kodak *1368 relied on its constructive reduction to practice date, in particular, the filing date of a parent application, to antedate Rexam’s asserted date of invention. In 1994, the Board entered judgment deciding the priority issue in favor of Kodak, but did not decide the issues of validity and enforceability of Rexam’s patent that Kodak had asserted. Rexam then challenged the Board’s decision in the district court pursuant to 35 U.S.C. § 146 (1994). It is this section 146 proceeding, described further below, from which the certified questions that are the subject of this appeal arise.

The ’738 Interference

After Avery and Kodak became aware that the Board would probably declare an interference between Avery’s U.S. Patent Application No. 08/419,837 (the ’837 application) and Kodak’s ’050 application, the parties executed an agreement in which, inter alia, they agreed that neither party would challenge the Board’s priority decision if the Board did declare and adjudicate such an interference. In 1996 the Board declared the ’738 interference between these applications. As in the ’667 interference, the ’738 interference again concerned claims 66-76 of the ’050 application, and Kodak again based its priority argument on its constructive reduction to practice.

In 1997, the Board entered judgment deciding priority in favor of Avery. Pursuant to its agreement with Avery, Kodak allowed the Board’s decision to become final. As a result, claims 66-76 of the ’050 application became unpatentable to Kodak. However, Kodak did not expressly abandon that application.

The Section H6 District Court Proceeding

Rexam initiated suit against Kodak in the district court pursuant to 35 U.S.C. § 146 to challenge the Board’s decision in the ’667 interference. 2 Rexam and Kodak both reasserted the priority arguments they had made before the Board. Kodak also reasserted its arguments that the claims in Rexam’s patent were invalid and/or unenforceable.

After the Board’s decision in the ’738 interference became final, Rexam moved for summary judgment in the section 146 proceeding. 3 Rexam argued that Kodak had abandoned its constructive reduction to practice by permitting the ’738 interference decision to become final, and that Kodak’s concession of priority to Avery should be treated as a request for entry of an adverse judgment against Kodak in the section 146 proceeding under 37 C.F.R. § 1.662(a). 4

The district court denied Rexam’s motion, concluding that Kodak’s loss of priority in the ’738 interference did not prohibit Kodak from defending its priority judgment against Rexam. However, the court certified the questions recited above for interlocutory appeal under 28 U.S.C. § 1292(b), whereupon Rexam petitioned this court for permission to appeal the questions. We granted the petition.

*1369 DISCUSSION

In addition to arguing the merits of the certified questions, Rexam also argues that the section 146 action is moot as a result of Kodak’s loss in the ’738 interference. We address the certified questions first.

Rexam argues that because Kodak’s ’050 application cannot mature into a patent containing claims 66-76, Kodak should be precluded from continuing to assert its priority in the section 146 proceeding, and that the first certified question should therefore be answered in the negative. Kodak responds that our precedent refutes Rexam’s argument. We agree with Kodak.

While no language in section 146 of the patent statute expressly addresses this issue, section 135(a) of the statute and our case law interpreting that provision provide substantial guidance for our analysis. The recently amended version of 35 U.S.C. § 135(a) provides that the Board “shall determine questions of priority of the inventions and may determine questions of patentability.” 35 U.S.C. § 135(a) (1994). 5 We interpreted this new language broadly in Perkins v. Kwon, 886 F.2d 325

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Abbott GmbH & Co. v. Centocor Ortho Biotech, Inc.
870 F. Supp. 2d 206 (D. Massachusetts, 2012)
Solvay S.A. v. Honeywell International, Inc.
622 F.3d 1367 (Federal Circuit, 2010)
Human Genome Sciences, Inc. v. Amgen, Inc.
553 F. Supp. 2d 353 (D. Delaware, 2008)
Church & Dwight Co. v. Abbott Laboratories
545 F. Supp. 2d 447 (D. New Jersey, 2008)
Freedom Wireless, Inc. v. Boston Communications Group, Inc.
369 F. Supp. 2d 159 (D. Massachusetts, 2005)
In Re Scott T. Jolley
308 F.3d 1317 (Federal Circuit, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
182 F.3d 1366, 51 U.S.P.Q. 2d (BNA) 1457, 1999 U.S. App. LEXIS 16013, 1999 WL 499491, Counsel Stack Legal Research, https://law.counselstack.com/opinion/rexam-industries-corp-v-eastman-kodak-company-and-avery-dennison-cafc-1999.